Knowledge Gaps and Emerging Research Areas in Intrauterine Growth Restriction-Associated Brain Injury
Year: 2019
Type: review
Abstract: Intrauterine growth restriction (IUGR) is a complex global healthcare issue. Concerted research and clinical efforts have improved our knowledge of the neurodevelopmental sequelae of IUGR which has raised the profile of this complex problem. Nevertheless, there is still a lack of therapies to prevent the substantial rates of fetal demise or the constellation of permanent neurological deficits that arise from IUGR. The purpose of this article is to highlight the clinical and translational gaps in our knowledge that hamper our collective efforts to improve the neurological sequelae of IUGR. Also, we draw attention to cutting-edge tools and techniques that can provide novel insights into this disorder, and technologies that offer the potential for better drug design and delivery. We cover topics including: how we can improve our use of crib-side monitoring options, what we still need to know about inflammation in IUGR, the necessity for more human post-mortem studies, lessons from improved integrated histology-imaging analyses regarding the cell-specific nature of magnetic resonance imaging (MRI) signals, options to improve risk stratification with genomic analysis, and treatments mediated by nanoparticle delivery which are designed to modify specific cell functions.
Source: Frontiers in Endocrinology
Institutions: St Thomas' Hospital, Inserm, King's College London, Sorbonne Paris Cité, Université Paris Diderot, NeuroDiderot, RMIT University, Hudson Institute of Medical Research, Monash Children’s Hospital, Monash University, The University of Melbourne, Mercy Hospital for Women, University of Geneva, University Hospital of Geneva, PremUP
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,950
OpenAlex ID: W2930557967
